A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis

Recruiting

Phase 2

Phase 3

A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis

Sponsor:

Nature Cell Co. Ltd.

Code:

NCT04368806

Conditions

Osteoarthritis, Knee

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JointStem

Placebo Control

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-10. This information was provided to ClinicalTrials.gov by Nature Cell Co. Ltd. on 2023-11-09.